Earnings History Data for ABIOMED, Inc. (ABMD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ABIOMED, Inc.

Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company'sproducts are used in the cardiac catheterization lab, or cath lab, by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
01-11-2022	PM	7:00 AM ET (Nov 1)	ABMD	ABIOMED, Inc.	11,730	1.30	1.04	1.03	Abiomed reports mixed FQ2 earnings [11/1/2022 7:13 AM]	377.80	125.72 (49.87%)	379.50	127.42 (50.55%)	219.84 - 381.99	6,165,603	300,000	429,888
Abiomed's Impella RP Flex gets FDA approval to treat right heart failure [10/31/2022 9:44 AM] Abiomed reports mixed FQ2 earnings [11/1/2022 7:13 AM] Abiomed climbs 52% on $380/share buyout deal with Johnson & Johnson [11/1/2022 7:54 AM] Johnson & Johnson said to have approached Abiomed [11/1/2022 9:47 AM] Abiomed unlikely to see higher bid given size of J&J premium - analyst [11/1/2022 1:51 PM] Abiomed Stock Price Surges on J&J Buyout [Nov-01-22 07:09AM] Abiomed Stock Surges on Johnson & Johnson Takeover [Nov-01-22 07:07AM] Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*, up 7% on a Reported Basis Year Over Year [Nov-01-22 07:00AM] Abiomed stock rockets after J&J buyout deal valued at $16.6 billion [Nov-01-22 06:43AM] UPDATE 2-J&J to buy Abiomed in $16.6 bln deal to boost cardiovascular business [Nov-01-22 06:42AM] J&J to buy Abiomed in $16.6 billion deal to boost cardiovascular business [Nov-01-22 06:41AM] Johnson & Johnson to Acquire Abiomed [Nov-01-22 06:30AM] MedTech Stocks Due to Report Earnings on Nov 1: MCK, CTLT & More [Oct-31-22 11:35AM] Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure [Oct-31-22 08:02AM]
04-08-2022	PM	7:00 AM ET (Aug 4)	ABMD	ABIOMED, Inc.	12,850	1.25	1.09	1.10		292.17	-9.29 (-3.08%)	301.46	0.0 (0.00%)	219.84 - 379.30	347,178	240,000	15,145
Abiomed FQ1 2023 Earnings Preview [8/3/2022 11:56 AM] Abiomed beats top and bottom line; guides FY 2023 topline growth of 13-17% [8/4/2022 7:02 AM] Abiomed shares fall as med tech lowers 2022 revenue guidance [8/4/2022 2:31 PM]
28-04-2022	PM	7:00 AM ET (Apr 28)	ABMD	ABIOMED, Inc.	13,010	1.16	1.09	1.24	Abiomed Non-GAAP EPS of $1.16 beats by $0.11, revenue of $270M beats by $2.33M [4/28/2022 7:02 AM]	286.69	9.54 (3.44%)	290.00	12.85 (4.64%)	261.27 - 379.30	431,115	270,000	1,009
Abiomed Q4 2022 Earnings Preview [4/27/2022 12:57 PM] Abiomed Non-GAAP EPS of $1.16 beats by $0.11, revenue of $270M beats by $2.33M [4/28/2022 7:02 AM] Integra LifeSciences (IART) Tops Q1 Earnings and Revenue Estimates [Apr-27-22 07:15AM] MedTech Stocks' Apr 28 Earnings Roster: ABMD, SYK & More [Apr-27-22 07:13AM] Abiomed Announces Fourth Quarter Record Revenue of $270 Million, up 12% Year Over Year [Apr-28-22 07:00AM] Abiomed (ABMD) Q4 Earnings and Revenues Surpass Estimates [Apr-28-22 08:52AM]
03-02-2022	PM	7:00 AM ET (Feb 3)	ABMD	ABIOMED, Inc.	13,460	1.13	0.98	1.17	Abiomed Non-GAAP EPS of $1.13 beats by $0.16, revenue of $261.18M beats by $9.71M [2/3/2022 7:10 AM]	291.07	-16.89 (-5.48%)	308.00	0.04 (0.01%)	261.27 - 379.30	689,439	620,000	447
Abiomed Q3 2022 Earnings Preview [2/2/2022 2:23 PM] Abiomed Non-GAAP EPS of $1.13 beats by $0.16, revenue of $261.18M beats by $9.71M [2/3/2022 7:10 AM] Abiomed Announces Record Revenue of $261 Million, up 13% Year Over Year [Feb-03-22 07:00AM] Abiomed (ABMD) Q3 Earnings and Revenues Top Estimates [Feb-03-22 08:35AM] Abiomed (ABMD) Beats on Q3 Earnings, Narrows FY22 Guidance [Feb-03-22 01:09PM]
28-10-2021	PM	7:00 AM ET (Oct 28)	ABMD	ABIOMED, Inc.	15,810	1.03	0.98	1.01	Abiomed EPS beats by $0.03, revenue in-line [10/28/2021 7:03 AM]	342.90	-1.68 (-0.49%)	330.10	-14.48 (-4.20%)	242.73 - 387.40	485,798	170,000	976
Abiomed FQ2 2022 Earnings Preview [10/27/2021 12:54 PM] Abiomed EPS beats by $0.03, revenue in-line, cuts FY guidance [10/28/2021 7:03 AM] Abiomed shares fall after Q3 earnings results, FY forecast [10/28/2021 10:46 AM] Abiomed Announces Q2 FY 2022 Revenue of $248 Million, Up 18% Year Over Year [Oct-28-21 07:00AM] Abiomed (ABMD) Beats on Q2 Earnings, Lowers FY22 Guidance [Oct-28-21 09:22AM] Abiomed (ABMD) Q2 Earnings Beat Estimates [Oct-28-21 09:15AM] ABIOMED, inc (ABMD) Q2 2022 Earnings Call Transcript [Oct-28-21 02:00PM]
29-04-2021	PM	7:00 AM ET (Apr 29)	ABMD	ABIOMED, Inc.	15,750	1.24	1.10	1.00	Abiomed EPS misses by $0.06, beats on revenue [4/29/2021 7:07 AM]	322.94	-28.23 (-8.04%)	322.94	0.0 (0.00%)	164.75 - 387.40	387,370	250,000	1,544
Abiomed FQ4 2021 Earnings Preview [4/28/2021 12:53 PM] Abiomed EPS misses by $0.06, beats on revenue [4/29/2021 7:07 AM] Abiomed posts Q4 topline beat, provides 2022 forecast [4/29/2021 7:48 AM] Final Results from the National Cardiogenic Shock Initiative (NCSI) Study Demonstrate the Benefit of Early Cardiac Unloading with Impella [Apr-28-21 03:57PM] Dr. Paula A. Johnson Joins Abiomed Board of Directors [Apr-28-21 08:03AM] ABIOMED, Inc. to Host Earnings Call [Apr-29-21 05:45AM] Abiomed Announces Record Revenue of $241 Million, up 17% Year Over Year, With 26.0% Operating Margin [Apr-29-21 07:00AM] Abiomed (ABMD) Q4 Earnings and Revenues Surpass Estimates [Apr-29-21 08:45AM] Abiomed Inc (ABMD) Q4 2021 Earnings Call Transcript [Apr-29-21 01:30PM] ABIOMED (ABMD) Earnings and Revenues Beat Estimates in Q4 [Apr-29-21 01:43PM]
28-01-2021	PM	7:00 AM ET (Jan 28)	ABMD	ABIOMED, Inc.	15,400	1.17	1.15	1.11	Abiomed EPS beats by $0.07, beats on revenue [1/28/2021 7:07 AM]	354.91	26.31 (8.01%)	340.00	11.40 (3.47%)	119.01 - 387.40	896,326	385,225	2,568
Abiomed EPS beats by $0.07, beats on revenue [1/28/2021 7:07 AM] Abiomed FQ3 2021 Earnings Preview [1/27/2021 1:24 PM] Abiomed topline up 5%, beats FQ3 consensus [1/28/2021 10:02 AM] Why Abiomed Stock Popped Today [Jan-28-21 01:51PM] ABIOMED (ABMD) Earnings and Revenues Beat Estimates in Q3 [Jan-28-21 12:10PM] Abiomed (ABMD) Q3 Earnings and Revenues Beat Estimates [Jan-28-21 08:35AM] Abiomed Announces Q3 FY 2021 Record Revenue of $232 Million, up 5% Year Over Year, With 31% Operating Margin [Jan-28-21 07:00AM] ABIOMED, Inc. to Host Earnings Call [Jan-28-21 05:45AM]
29-10-2020	PM	7:00 AM ET (Oct 29)	ABMD	ABIOMED, Inc.	13,090	1.01	0.87	1.03	Abiomed EPS beats by $0.04, beats on revenue [10/29/2020 7:05 AM]	254.61	-28.39 (-10.03%)	283.00	0.0 (0.00%)	119.01 - 319.19	826,031	273,111	177

06-08-2020	PM	7:00 AM ET (Aug 6)	ABMD	ABIOMED, Inc.	13,890	0.58	0.20	1.00	Abiomed EPS beats by $0.26, beats on revenue [8/6/2020 7:08 AM]	311.90	-5.11 (-1.61%)	317.00	0.0 (0.00%)	119.01 - 319.19	219,363	297,625	5,683